$126 Million is the total value of JW Asset Management, LLC's 38 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EGRX | Sell | EAGLE PHARMACEUTICALS INC | $20,383,000 | -33.8% | 525,479 | -30.9% | 16.20% | -19.4% |
| AMZN | Buy | AMAZON COM INC COM | $14,312,000 | +158.2% | 20,000 | +114.2% | 11.38% | +214.3% |
| FB | Sell | FACEBOOK INC CLASS A COMMON STOCKcl a | $10,628,000 | -29.3% | 93,000 | -29.4% | 8.45% | -13.9% |
| HZNP | Sell | HORIZON PHARMA PLC | $10,361,000 | -7.1% | 629,075 | -6.5% | 8.24% | +13.1% |
| New | CALL AMZN AUG 00685 AMAZON COM INC COM EXP 08-19-16call | $10,275,000 | – | 150 | +100.0% | 8.17% | – | |
| ARLZ | Buy | ARALEZ PHARMACEUTICALS INC | $9,033,000 | +38.6% | 2,737,140 | +49.1% | 7.18% | +68.7% |
| BX | BLACKSTONE GROUP LP COM UNIT REPSTG L P | $7,240,000 | -12.5% | 295,009 | 0.0% | 5.76% | +6.5% | |
| AKRXQ | Buy | AKORN INCORP LA | $5,270,000 | +1258.2% | 184,998 | +1020.8% | 4.19% | +1555.7% |
| FLML | Sell | FLAMEL TECH SPNSRD ADRsponsored adr | $4,773,000 | -8.9% | 444,439 | -6.3% | 3.79% | +10.9% |
| LGND | LIGAND PHARMACEUTICALS INC SHS CL B | $4,314,000 | +11.4% | 36,174 | 0.0% | 3.43% | +35.5% | |
| WING | WINGSTOP INC | $3,163,000 | +20.2% | 116,057 | 0.0% | 2.51% | +46.2% | |
| BSTC | BIOSPECIFICS TECHNLGY CP | $2,902,000 | +14.7% | 72,649 | 0.0% | 2.31% | +39.6% | |
| JNP | JUNIPER PHARMACEUTICALS INC | $2,300,000 | +6.0% | 328,132 | 0.0% | 1.83% | +29.1% | |
| QLTI | QLT INC-CANADA COM | $2,262,000 | -28.6% | 1,592,993 | 0.0% | 1.80% | -13.1% | |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $2,207,000 | – | 30,000 | +100.0% | 1.75% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $2,118,000 | – | 15,000 | +100.0% | 1.68% | – |
| INSYQ | Sell | INSYS THERAPEUTICS INC NEW | $1,949,000 | -45.0% | 150,638 | -32.0% | 1.55% | -33.0% |
| CBM | CAMBREX CORP COM | $1,818,000 | +17.5% | 35,148 | 0.0% | 1.44% | +43.1% | |
| ISRG | New | INTUITIVE SURGICAL INC NEW | $1,654,000 | – | 2,500 | +100.0% | 1.32% | – |
| CRM | New | SALESFORCE COM INC | $1,588,000 | – | 20,000 | +100.0% | 1.26% | – |
| SGNT | SAGENT PHARMACEUTCLS INC | $1,522,000 | +23.0% | 101,630 | 0.0% | 1.21% | +49.8% | |
| DEPO | Sell | DEPOMED INC | $1,136,000 | -30.9% | 57,924 | -50.9% | 0.90% | -15.8% |
| JNJ | New | JOHNSON AND JOHNSON COM | $728,000 | – | 6,000 | +100.0% | 0.58% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $600,000 | – | 189,919 | +100.0% | 0.48% | – |
| MLM | New | MARTIN MARIETTA MATLS | $576,000 | – | 3,000 | +100.0% | 0.46% | – |
| DRAD | DIGIRAD CORP | $568,000 | +3.8% | 110,257 | 0.0% | 0.45% | +26.3% | |
| ATRS | Buy | ANTARES PHARMA INC | $500,000 | +303.2% | 475,897 | +234.7% | 0.40% | +390.1% |
| ADMS | ADAMAS PHARMACEUTICALS INC | $456,000 | +4.6% | 30,140 | 0.0% | 0.36% | +27.0% | |
| XNPT | XENOPORT INC | $352,000 | +55.8% | 50,000 | 0.0% | 0.28% | +89.2% | |
| TLGT | Sell | TELIGENT INC | $314,000 | +0.3% | 43,920 | -31.2% | 0.25% | +22.5% |
| PJT | Buy | PJT PARTNERS INC SHS CL A | $230,000 | +91.7% | 10,000 | +100.0% | 0.18% | +134.6% |
| FOLD | AMICUS THERAPEUTICS INC | $109,000 | -35.5% | 20,000 | 0.0% | 0.09% | -20.9% | |
| MTBC | MEDICAL TRANSCRIPTION BILLING CORP | $56,000 | -13.8% | 63,771 | 0.0% | 0.04% | +7.1% | |
| CPIX | CUMBERLAND PHARMA INC | $49,000 | 0.0% | 10,939 | 0.0% | 0.04% | +21.9% | |
| EYES | SECOND SIGHT MEDICAL PRODUCTS INC SHS | $30,000 | -26.8% | 8,500 | 0.0% | 0.02% | -11.1% | |
| CTIC | CTI BIOPHARMA CORP | $17,000 | -37.0% | 50,254 | 0.0% | 0.01% | -22.2% | |
| AVIR | New | AVIRAGEN THERAPEUTICS INC | $12,000 | – | 8,611 | +100.0% | 0.01% | – |
| NSPH | NANOSPHERE INC | $6,000 | +100.0% | 3,451 | 0.0% | 0.01% | +150.0% | |
| BOTA | Exit | BIOTA PHARMACEUTICALS INC | $0 | – | -8,611 | -100.0% | -0.01% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -17,974 | -100.0% | -0.23% | – |
| CMG | Exit | CHIPOTLE MEXICAN GRILL | $0 | – | -2,000 | -100.0% | -0.62% | – |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES INC | $0 | – | -189,919 | -100.0% | -0.64% | – |
| IPXL | Exit | IMPAX LABS INC | $0 | – | -53,373 | -100.0% | -1.12% | – |
| NFLX | Exit | NETFLIX COM INC | $0 | – | -17,484 | -100.0% | -1.17% | – |
| ALXN | Exit | ALEXION PHARMS INC | $0 | – | -25,424 | -100.0% | -2.31% | – |
| GOOG | Exit | ALPHABET INC SHS CL Ccap stk cl c | $0 | – | -6,064 | -100.0% | -2.95% | – |
| CXRX | Exit | CONCORDIA HEALTHCARE CORP SHS | $0 | – | -245,400 | -100.0% | -4.10% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -44,189 | -100.0% | -7.73% | – |
| SBUX | Exit | STARBUCKS CORP | $0 | – | -230,690 | -100.0% | -8.99% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
| ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
| EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
| HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
| HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
| LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
| BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
| MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
| CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
| EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 4 | 2024-01-02 |
| SC 13D/A | 2024-01-02 |
| 4 | 2023-12-26 |
| 4 | 2023-12-19 |
| 4 | 2023-12-12 |
| 4 | 2023-12-07 |
| 4 | 2023-12-06 |
| 4 | 2023-11-21 |
| 4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.